Handbook of Clinical Nanomedicine : Law, Business, Regulation, Safety, and Risk

This unique handbook (60 chapters) examines the entire "product life cycle," from the creation of nanomedical products to their final market introduction. While focusing on critical issues relevant to nanoproduct development and translational activities, it tackles topics such as regulatory science, patent law, FDA law, ethics, personalized medicine, risk analysis, toxicology, nano-characterization and commercialization activities. A separate section provides fascinating perspectives and editorials from leading experts in this complex interdisciplinary field.

The exciting advances in nanomedicine in the past two decades highlight the growing need for an authoritative and comprehensive reference that can be relied upon by scientists, clinicians, academics, industry, students, lawyers, and policy-makers alike. With this in mind, the Handbook of Clinical Nanomedicine: Law, Business, Regulation, Safety, and Risk and its related companion volumes in the series aim to provide a broad survey of interconnected topics pertaining to clinical nanomedicine. This is the second volume in the series. Each volume is intended to be a stand‐alone reference source, presented in a user-friendly format for easy access.